Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy.
Ontology highlight
ABSTRACT: Treatment options for refractory hepatic encephalopathy (HE) are limited. Patients who fail medical management may harbor large portosystemic shunts (PSSs) which are possible therapeutic targets. This study aims to describe patient selection, effectiveness, and safety of percutaneous PSS embolization in those with medically refractory HE. A retrospective evaluation of consecutive adult patients with medically refractory HE referred for PSS embolization at a tertiary center was performed (2003-2015). Patient data collected included the type of HE, medications, Model for End-Stage Liver Disease (MELD) score, shunt type, embolization approach, and materials used. Outcomes of interest were immediate (7 days), intermediate (1-4 months), and longer-term (6-12 months) effectiveness and periproced
SUBMITTER: Lynn AM
PROVIDER: S-EPMC4917293 | biostudies-literature | 2016 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA